Published in Neurology on September 12, 2000
GPs' classification of headache: is primary headache underdiagnosed? Br J Gen Pract (2008) 1.74
Atypical resting-state functional connectivity of affective pain regions in chronic migraine. Headache (2013) 1.70
Paracetamol use in pregnancy and wheezing in early childhood. Thorax (2002) 1.62
Spinal Cord Injury and Migraine Headache: A Population-Based Study. PLoS One (2015) 1.40
Impact of headache in Europe: a review for the Eurolight project. J Headache Pain (2008) 1.21
Advanced neuroimaging of migraine. Lancet Neurol (2009) 1.19
Population-based study of migraine in Spanish adults: relation to socio-demographic factors, lifestyle and co-morbidity with other conditions. J Headache Pain (2009) 1.18
A high-density association screen of 155 ion transport genes for involvement with common migraine. Hum Mol Genet (2008) 1.17
A qualitative study of migraine involving patient researchers. Br J Gen Pract (2005) 1.16
Intrinsic brain network abnormalities in migraines without aura revealed in resting-state fMRI. PLoS One (2012) 1.14
Physical and mental comorbidity of headache in a nationally representative sample of US adults. Psychosom Med (2008) 1.12
Impaired functioning and quality of life in severe migraine: the role of catastrophizing and associated symptoms. Cephalalgia (2007) 1.05
Prophylaxis of migraine: general principles and patient acceptance. Neuropsychiatr Dis Treat (2008) 0.98
Gender-related differences in the dysfunctional resting networks of migraine suffers. PLoS One (2011) 0.97
Migraine in women with chronic pelvic pain with and without endometriosis. Fertil Steril (2010) 0.96
Headache Impact Test-6 (HIT-6) scores for migraine patients: Their relation to disability as measured from a headache diary. J Clin Neurol (2008) 0.95
Will (or can) people pay for headache care in a poor country? J Headache Pain (2011) 0.92
The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials. Health Qual Life Outcomes (2007) 0.91
The impact of migraine and the effect of migraine treatment on workplace productivity in the United States and suggestions for future research. Mayo Clin Proc (2009) 0.90
Headache disorders: differentiating and managing the common subtypes. Br J Pain (2012) 0.88
Patient outcome in migraine prophylaxis: the role of psychopharmacological agents. Patient Relat Outcome Meas (2010) 0.88
The validation of the Italian Perceived Disability Scale (IPDS) in chronic daily headache sufferers. J Headache Pain (2008) 0.87
Therapeutic antibodies against CGRP or its receptor. Br J Clin Pharmacol (2015) 0.86
Topiramate in the prevention of migraine: a review of its efficacy, tolerability, and acceptability. Neuropsychiatr Dis Treat (2006) 0.83
A proactive approach to migraine in primary care: a pragmatic randomized controlled trial. CMAJ (2012) 0.83
Reduction in the impact of chronic migraine with medication overuse after day-hospital withdrawal therapy. Neurol Sci (2008) 0.82
Factors associated with migraine-related quality of life and disability in adolescents: a preliminary investigation. Headache (2003) 0.82
Quality of life and migraine disability among female migraine patients in a tertiary hospital in Malaysia. Biomed Res Int (2015) 0.82
The prevalence of fibromyalgia and its relation with headache characteristics in episodic migraine. Clin Rheumatol (2013) 0.81
Influence of temple headache frequency on physical functioning and emotional functioning in subjects with temporomandibular disorder pain. J Orofac Pain (2012) 0.80
Simvastatin and vitamin D for migraine prevention: A randomized, controlled trial. Ann Neurol (2015) 0.80
Kynurenines and headache. J Neural Transm (Vienna) (2011) 0.79
Interictal neurocognitive processing of visual stimuli in migraine: evidence from event-related potentials. PLoS One (2013) 0.79
Behavioural management of migraine. Ann Indian Acad Neurol (2012) 0.78
What does it mean to have migraine? Neurology (2000) 0.78
A pilot study of topiramate dosages for migraine prophylaxis in an Asian population. J Headache Pain (2010) 0.77
Comparison of validity and reliability of the Migraine disability assessment (MIDAS) versus headache impact test (HIT) in an Iranian population. Iran J Neurol (2011) 0.77
Assessing risk factors for migraine: differences in gender transmission. PLoS One (2012) 0.76
Humanistic and economic burden of nausea and vomiting among migraine sufferers. J Pain Res (2017) 0.75
Migraine-asthma comorbidity and risk of hypertensive disorders of pregnancy. J Pregnancy (2012) 0.75
Health care utilization and changes in health status over time for migraineurs. Pain Res Manag (2007) 0.75
Developments in managing severe chronic pain: role of oxycodone-naloxone extended release. Drug Des Devel Ther (2015) 0.75
Key points in migraine prophylaxis: patient perspective. Neurol Sci (2009) 0.75
Underdiagnosis of primary headaches: results of a survey on patients attending headache centres. Neurol Sci (2009) 0.75
Health-related quality of life and ways of coping with stress in patients with migraine. Neurol Sci (2016) 0.75
Adverse reactions related to drugs for headache treatment: clinical impact. Eur J Clin Pharmacol (2005) 0.75
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med (2001) 7.85
Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell (1996) 5.99
Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 3.39
Migraine headache is not associated with cerebral or meningeal vasodilatation--a 3T magnetic resonance angiography study. Brain (2008) 3.38
Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia (2000) 3.32
CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study. Neurology (2003) 3.18
Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment. J Neurol (1999) 2.92
Cardiovascular risk factors and migraine: the GEM population-based study. Neurology (2005) 2.86
The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology (1999) 2.69
Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol (1997) 2.67
Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study. Am J Epidemiol (1996) 2.45
Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.45
Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.43
Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology (2002) 2.42
NSAIDs and incident Alzheimer's disease. The Rotterdam Study. Neurobiol Aging (1999) 2.41
Syncope in migraine: the population-based CAMERA study. Neurology (2006) 2.33
Health interview surveys. Towards international harmonization of methods and instruments. WHO Reg Publ Eur Ser (1996) 2.29
Comparison of rizatriptan and other triptans on stringent measures of efficacy. Neurology (2001) 2.29
Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging Study. Neurobiol Aging (2000) 2.26
Towards a definition of intractable headache for use in clinical practice and trials. Cephalalgia (2006) 2.23
Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study. Arterioscler Thromb Vasc Biol (2000) 2.16
Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study. Neurology (2001) 2.15
Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology (1999) 2.13
Iron accumulation in deep brain nuclei in migraine: a population-based magnetic resonance imaging study. Cephalalgia (2008) 2.12
Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee. Neurology (2000) 2.10
Tea flavonoids may protect against atherosclerosis: the Rotterdam Study. Arch Intern Med (1999) 2.09
Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location. J Neurol Neurosurg Psychiatry (2008) 1.99
Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability. J Neurol (1995) 1.87
Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes. Neurology (2002) 1.82
Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. Am J Epidemiol (1997) 1.81
Memory complaints and memory impairment in older individuals. J Am Geriatr Soc (1996) 1.79
Prognosis with dementia in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 1.76
Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology (2004) 1.73
Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia. Arch Neurol (1998) 1.67
Selective seratonin 1F (5-HT(1F)) receptor agonist LY334370 for acute migraine: a randomised controlled trial. Lancet (2001) 1.63
Shared genetic factors in migraine and depression: evidence from a genetic isolate. Neurology (2010) 1.61
Physical activity and cognitive decline, the role of the apolipoprotein e4 allele. Med Sci Sports Exerc (2001) 1.61
Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe. Neurology (2005) 1.59
Abnormal transmitter release at neuromuscular junctions of mice carrying the tottering alpha(1A) Ca(2+) channel mutation. Brain (2000) 1.56
Epidemiology of Alzheimer's disease. Epidemiol Rev (1992) 1.56
Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study. Cephalalgia (2010) 1.56
Hereditary vascular retinopathy, cerebroretinal vasculopathy, and hereditary endotheliopathy with retinopathy, nephropathy, and stroke map to a single locus on chromosome 3p21.1-p21.3. Am J Hum Genet (2001) 1.54
Ergotamine in the acute treatment of migraine: a review and European consensus. Brain (2000) 1.52
Expanding the phenotypic spectrum of the CACNA1A gene T666M mutation: a description of 5 families with familial hemiplegic migraine. Arch Neurol (2003) 1.51
Familial cyclic vomiting syndrome. Cephalalgia (2002) 1.49
Features involved in the diagnostic delay of cluster headache. J Neurol Neurosurg Psychiatry (2003) 1.47
Is familial hemiplegic migraine a hereditary form of basilar migraine? Cephalalgia (1995) 1.46
Single-fiber EMG in familial hemiplegic migraine. Neurology (2004) 1.46
Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study. Neurology (1995) 1.45
Risk factors for headache recurrence after sumatriptan: a study in 366 migraine patients. Cephalalgia (1996) 1.43
Effect of smoking on global cognitive function in nondemented elderly. Neurology (2004) 1.42
Blood flow velocity changes in migraine attacks--a transcranial Doppler study. Cephalalgia (1991) 1.42
No involvement of the calcium channel gene (CACNA1A) in a family with cluster headache. Cephalalgia (2001) 1.40
Impairment of trigeminal sensory pathways in cluster headache. Cephalalgia (2003) 1.39
[Still no proof of the efficacy of acupuncture in the prevention of migraine]. Ned Tijdschr Geneeskd (2004) 1.39
Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine. Ann Neurol (2001) 1.39
No confirmation of visual evoked potential diagnostic test for migraine. Lancet (1991) 1.39
Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men. Diabetologia (1995) 1.38
Coronary side-effect potential of current and prospective antimigraine drugs. Circulation (1998) 1.36
Hippocampal shape analysis in Alzheimer's disease: a population-based study. Neuroimage (2007) 1.35
Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. Am J Epidemiol (1999) 1.32
Apolipoprotein e4 allele and cognitive decline in elderly men. BMJ (1994) 1.31
Cerebral microbleeds, retinopathy, and dementia: the AGES-Reykjavik Study. Neurology (2010) 1.29
Joint effect of the APOE gene and midlife systolic blood pressure on late-life cognitive impairment: the Honolulu-Asia aging study. Stroke (2001) 1.28
Smoking cessation and quality of life: the effect of amount of smoking and time since quitting. Prev Med (2001) 1.20
Cohort study of effect of being overweight and change in weight on risk of coronary heart disease in old age. BMJ (1997) 1.20
Tea and coronary heart disease: protection through estrogen-like activity? Arch Intern Med (2000) 1.16
Coffee consumption is inversely associated with cognitive decline in elderly European men: the FINE Study. Eur J Clin Nutr (2006) 1.16
Serum estradiol and risk of stroke in elderly men. Neurology (2007) 1.16
Serum thyroxine level and cognitive decline in euthyroid older women. Neurology (2002) 1.14
Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study. Arch Intern Med (1999) 1.14
Cerebral microbleeds in CADASIL. Neurology (2001) 1.13
Lifestyle risk factors for cancer: the relationship with psychosocial work environment. Int J Epidemiol (2000) 1.12
Progression of cerebral white matter hyperintensities on MRI is related to diastolic blood pressure. Neurology (1998) 1.11
Analysis and validation of automated skull stripping tools: a validation study based on 296 MR images from the Honolulu Asia aging study. Neuroimage (2006) 1.11
Chronic frequent headache in the general population: prevalence and associated factors. Cephalalgia (2006) 1.11
MRI correlates of cognitive decline in CADASIL: a 7-year follow-up study. Neurology (2009) 1.10
Antimigraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attacks. Neurology (1992) 1.10
Severe episodic neurological deficits and permanent mental retardation in a child with a novel FHM2 ATP1A2 mutation. Ann Neurol (2006) 1.09
Parkinsonism, tardive dyskinesia, akathisia, and depression induced by flunarizine. Lancet (1986) 1.09
5-HT(1)-like receptor agonists and the pathophysiology of migraine. Trends Pharmacol Sci (1989) 1.09
Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men. Stroke (1996) 1.08
Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility gene. Transl Psychiatry (2014) 1.07
Validity of retrospective diet history: assessing recall of midlife diet using food frequency questionnaire in later life. J Nutr Health Aging (2011) 1.06
Migraine aura, illusory vertical splitting, and Picasso. Cephalalgia (2000) 1.06
Dietary antioxidants and Parkinson disease. The Rotterdam Study. Arch Neurol (1997) 1.05
Alternating hemiplegia of childhood successfully treated with topiramate: 18 months of follow-up. Neurology (2006) 1.05
A prospective study on cortisol, dehydroepiandrosterone sulfate, and cognitive function in the elderly. J Clin Endocrinol Metab (1998) 1.04
TREX1 gene variant in neuropsychiatric systemic lupus erythematosus. Ann Rheum Dis (2009) 1.04
Diagnostic Notch3 sequence analysis in CADASIL: three new mutations in Dutch patients. Dutch CADASIL Research Group. Neurology (1999) 1.03
Birth weight, growth, and blood pressure: an annual follow-up study of children aged 5 through 21 years. Hypertension (1997) 1.03
Clinical and genetic analysis of a large Dutch family with autosomal dominant vascular retinopathy, migraine and Raynaud's phenomenon. Brain (1998) 1.02
Sumatriptan-nonresponders: a survey in 366 migraine patients. Headache (1996) 1.02